Results 31 to 40 of about 45,555 (245)

Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Hematomas that slowly increase in size for more than 1 month after the initial hemorrhage are referred to as chronic expanding hematomas. Chronic expanding hematoma can also occur after radiosurgery; however, there have been no reports about ...
Yojiro Ishikawa   +6 more
doaj   +1 more source

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer

open access: yesThoracic Cancer, 2023
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early‐stage non‐small lung cancer (NSCLC).
Izabela Zarębska, Maciej Harat
doaj   +1 more source

LINAC stereotactic radiosurgery for trigeminal neuralgia –retrospective two-institutional examination of treatment outcomes

open access: yesRadiation Oncology, 2018
Background In this pooled 2-center series LINAC radiosurgery (SRS) has been applied as a treatment option for a subset of refractory trigeminal neuralgia (TN) patients.
Ali Rashid   +5 more
doaj   +1 more source

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases

open access: yesSurgical Neurology International, 2013
Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (HFSRT) have become important treatment modalities for brain metastases. While effective, there are still areas of extensive debate on its appropriate use in patients with life-limiting diseases.
Halasz, Lia M., Rockhill, Jason K.
openaire   +2 more sources

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

open access: yesFrontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani   +3 more
doaj   +1 more source

Optic-guided stereotactic radiotherapy

open access: yesMedical Dosimetry, 1998
Stereotactic localization provides a powerful referencing system for radiation planning and treatment delivery. Although the standard approach of applying a rigid reference frame has been accepted for single-fraction therapy, a new, noninvasive approach is needed for fractionated therapy.
Departments of Radiation Oncology, Gainesville, FL, USA ( host institution )   +4 more
openaire   +3 more sources

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?

open access: yesClinical and Translational Radiation Oncology, 2019
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few
Alexander Rühle   +3 more
doaj   +1 more source

Stereotactic radiotherapy for brain oligometastases

open access: yesReports of Practical Oncology and Radiotherapy, 2022
Brain metastases, the most common metastases in adults, will develop in up to 40% of cancer patients, accounting for more than one-half of all intracranial tumors. They are most associated with breast and lung cancer, melanoma and, less frequently, colorectal and kidney carcinoma. Magnetic resonance imaging (MRI) is the gold standard for diagnosis. For
Lupattelli M.   +9 more
openaire   +7 more sources

Stereotactic Body Radiotherapy

open access: yes, 2017
Stereotactic body radiation therapy (SBRT) consists of the delivery of precise, conformal, hypofractionated, and ablative therapy in a single or a small number of fractions to extracranial regions. Over the last decade, it is rapidly being integrated into mainstream radiation oncology practices.
Kothari, Gargi   +9 more
openaire   +3 more sources

Stereotactic body radiotherapy for oligometastases

open access: yesThe Lancet Oncology, 2013
The management of metastatic solid tumours has historically focused on systemic treatment given with palliative intent. However, radical surgical treatment of oligometastases is now common practice in some settings. The development of stereotactic body radiotherapy (SBRT), building on improvements in delivery achieved by intensity-modulated and image ...
Tree, A   +9 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy